BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38513326)

  • 1. Multivalent pyrrolidines acting as pharmacological chaperones against Gaucher disease.
    Borie-Guichot M; Lan Tran M; Garcia V; Oukhrib A; Rodriguez F; Turrin CO; Levade T; Génisson Y; Ballereau S; Dehoux C
    Bioorg Chem; 2024 May; 146():107295. PubMed ID: 38513326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorus Dendrimers for Metal-Free Ligation: Design of Multivalent Pharmacological Chaperones against Gaucher Disease.
    Tran ML; Borie-Guichot M; Garcia V; Oukhrib A; Génisson Y; Levade T; Ballereau S; Turrin CO; Dehoux C
    Chemistry; 2023 Sep; 29(53):e202301210. PubMed ID: 37313991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic investigation of iminosugar click clusters as pharmacological chaperones for the treatment of Gaucher disease.
    Joosten A; Decroocq C; de Sousa J; Schneider JP; Etamé E; Bodlenner A; Butters TD; Compain P
    Chembiochem; 2014 Jan; 15(2):309-19. PubMed ID: 24375964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease.
    Kato A; Nakagome I; Sato K; Yamamoto A; Adachi I; Nash RJ; Fleet GW; Natori Y; Watanabe Y; Imahori T; Yoshimura Y; Takahata H; Hirono S
    Org Biomol Chem; 2016 Jan; 14(3):1039-48. PubMed ID: 26633162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease.
    Parmeggiani C; Catarzi S; Matassini C; D'Adamio G; Morrone A; Goti A; Paoli P; Cardona F
    Chembiochem; 2015 Sep; 16(14):2054-64. PubMed ID: 26376302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.
    Martínez-Bailén M; Carmona AT; Cardona F; Matassini C; Goti A; Kubo M; Kato A; Robina I; Moreno-Vargas AJ
    Eur J Med Chem; 2020 Apr; 192():112173. PubMed ID: 32146376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4,5-Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers.
    Vanni C; Clemente F; Paoli P; Morrone A; Matassini C; Goti A; Cardona F
    Chembiochem; 2022 Jun; 23(11):e202200077. PubMed ID: 35322924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease.
    Laigre E; Hazelard D; Casas J; Serra-Vinardell J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Compain P
    Carbohydr Res; 2016 Jun; 429():98-104. PubMed ID: 27063390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring substituent diversity on pyrrolidine-aryltriazole iminosugars: Structural basis of β-glucocerebrosidase inhibition.
    Martínez-Bailén M; Carmona AT; Patterson-Orazem AC; Lieberman RL; Ide D; Kubo M; Kato A; Robina I; Moreno-Vargas AJ
    Bioorg Chem; 2019 May; 86():652-664. PubMed ID: 30825709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.
    Cheng WC; Weng CY; Yun WY; Chang SY; Lin YC; Tsai FJ; Huang FY; Chen YR
    Bioorg Med Chem; 2013 Sep; 21(17):5021-8. PubMed ID: 23880081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
    Wang GN; Reinkensmeier G; Zhang SW; Zhou J; Zhang LR; Zhang LH; Butters TD; Ye XS
    J Med Chem; 2009 May; 52(10):3146-9. PubMed ID: 19397268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the Inhibitor versus Chaperone Properties of sp²-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.
    Mena-Barragán T; García-Moreno MI; Sevšek A; Okazaki T; Nanba E; Higaki K; Martin NI; Pieters RJ; Fernández JMG; Mellet CO
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29673163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
    FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance.
    Wang Y; Xiao J; Meng A; Liu C
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocerebrosidase inhibitors for the treatment of Gaucher disease.
    Trapero A; Llebaria A
    Future Med Chem; 2013 Apr; 5(5):573-90. PubMed ID: 23573974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of the inhibition of GH1 β-glucosidases by multivalent pyrrolidine iminosugars.
    Martínez-Bailén M; Jiménez-Ortega E; Carmona AT; Robina I; Sanz-Aparicio J; Talens-Perales D; Polaina J; Matassini C; Cardona F; Moreno-Vargas AJ
    Bioorg Chem; 2019 Aug; 89():103026. PubMed ID: 31226649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a New α-1-
    Nakagome I; Kato A; Yamaotsu N; Yoshida T; Ozawa SI; Adachi I; Hirono S
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30340368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors.
    Baudoin-Dehoux C; Castellan T; Rodriguez F; Rives A; Stauffert F; Garcia V; Levade T; Compain P; Génisson Y
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30669468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise asymmetric synthesis of new enantiomeric
    Castellan T; Garcia V; Rodriguez F; Fabing I; Shchukin Y; Tran ML; Ballereau S; Levade T; Génisson Y; Dehoux C
    Org Biomol Chem; 2020 Oct; 18(39):7852-7861. PubMed ID: 32975266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor versus chaperone behaviour of d-fagomine, DAB and LAB sp(2)-iminosugar conjugates against glycosidases: A structure-activity relationship study in Gaucher fibroblasts.
    Mena-Barragán T; García-Moreno MI; Nanba E; Higaki K; Concia AL; Clapés P; García Fernández JM; Ortiz Mellet C
    Eur J Med Chem; 2016 Oct; 121():880-891. PubMed ID: 26361824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.